Annotation Detail for GRIN3B
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04080 | Neuroactive ligand-receptor interaction |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GRIN3B mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GRIN3B mRNA | affects expression | 16483693
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of GRIN3B mRNA | decreases expression | 19440498
|
D004026 |
Dieldrin |
Dieldrin affects the expression of GRIN3B mRNA | affects expression | 19440498
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of GRIN3B mRNA | increases expression | 15860345
|
D008727 |
Methotrexate |
GRIN3B protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D009532 |
Nickel |
Nickel results in increased expression of GRIN3B mRNA | increases expression | 19440498
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.64 | 12039119 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.89 | 16166738 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
4.74 | 17119214 11874814 16611668 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.29 | 10982225 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.15 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.13 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.13 | 18080171 19368416 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.30 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.30 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.30 | 15986119 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.40 | 3084413 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.31 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.73 | 10977129 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.66 | 12039119 9562676 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.50 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.15 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.86 | 11575062 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
4.30 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.94 | 2952479 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.45 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.65 | 16393943 16081117 19370779 11834606 18713872 14986274 11743745 16781746 17562736 10915739 10663392 12705907 11739529 17906064 12594235 19739265 11529661 16227642 19164858 11461765 2444490 17522070 19923254 12153990 16485898 12540782 14550746 18071297 19420014 12958197 10774834 19416960 15619225 11421492 12392966 15968718 19085960 16177239 14725611 11287661 16109766 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.54 | 19426721 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.12 | 16983495 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.51 | 16518429 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.94 | 17263646 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.92 | 16870215 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
5.24 | 10630421 |
MESH:D007249 |
Inflammation |
|
Nickel |
3.55 | 16166738 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.34 | 15629191 12587719 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.41 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.83 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.46 | 19014921 12587719 19784758 16610002 12969438 16611625 19460945 11587558 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
4.46 | 15991261 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.50 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
3.42 | 9539021 8742319 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.46 | 18516814 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.14 | 17352296 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.93 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
4.40 | 16856516 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.68 | 17488658 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
3.58 | 8820588 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.10 | 18514411 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
4.34 | 15081274 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.62 | 16870215 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.61 | 16112328 11181820 16809432 17291500 11445065 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.51 | 17410198 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.31 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
4.44 | 11575062 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.07 | 17352296 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.99 | 16611668 17119214 11874814 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
5.33 | 16611668 17119214 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
2.83 | 19369910 18513383 1830565 20107430 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
6.53 | 6418539 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.36 | 9562676 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
5.04 | 20210726 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.28 | 10982225 |
Pathway ID |
Pathway Name |
---|
KEGG:04724 |
Glutamatergic synapse |
KEGG:04080 |
Neuroactive ligand-receptor interaction |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00142 |
- |
L-Glutamic Acid |
Dietary supplement;Micronutrient;Non-Essential Amino Acids |
DB00145 |
- |
Glycine |
Dietary supplement;Micronutrient;Non-Essential Amino Acids;Glycine Agents |
DB01159 |
inhibitor |
Halothane |
Anesthetics, Inhalation;General Anesthetics;Anesthetics |
DB01173 |
antagonist |
Orphenadrine |
Skeletal Muscle Relaxants;Antiparkinson Agents;Antidyskinetics;Muscarinic Antagonists;Muscle Relaxants, Central;Parasympatholytics |
DB01520 |
antagonist |
Tenocyclidine |
Neuroprotective Agents;Anesthetics, Dissociative |